XenoPort: Manufacturing Delays Caused Stockout of Horizant – Fox Business

by admin on April 12, 2013

XenoPort: Manufacturing Delays Caused Stockout of Horizant
Fox Business
Dow Jones Newswires. Biopharmaceutical firm XenoPort Inc. (XNPT) said GlaxoSmithKline PLC (GSK, GSK.LN) has experienced manufacturing delays that resulted in stockout of Horizant, a restless-leg syndrome drug. Glaxo holds commercialization rights

and more »

View full post on restless leg syndrome – Google News

Leave a Comment

Previous post:

Next post: